East Millstone-based Envigo, a provider of nonclinical contract research services and models, announced Tuesday it has appointed Lynn Lewis its new senior vice president, global sales.
Lewis, who has extensive experience in the pharmaceuticals and contract research organization industries, will be responsible for strengthening the company’s position in the marketplace with a focus on customer service.
She will report to Craig Boyd, Evigo’s chief commercial officer.
“Given the dynamic growth in the CRO industry, there is an increasing opportunity to further engage our existing customers, as well as attract emerging life sciences companies to Envigo’s extensive nonclinical service offerings and research products. We are thrilled that Lynn Lewis has joined our team to drive this important effort,” said Adrian Hardy, CEO and president.
“Lynn’s broad experience leading billion-dollar, successful global sales organizations serving the biopharmaceutical industry will be an invaluable asset to our commercial team. Under her guidance, our sales teams in North America, Europe and Asia Pacific will be unified which will provide additional focus on enterprise-wide growth initiatives and an enhanced customer experience, while contributing to our vision to work together to build a healthier and safer world.”
Prior to Envigo, Lewis was at Covance as its group vice president of business development, clinical development and commercialization services.